• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺髓样癌中腱生蛋白C、表皮生长因子受体、E-钙黏蛋白和甲状腺转录因子-1的表达及其与RET突变状态的相关性

Expression of Tenascin C, EGFR, E-Cadherin, and TTF-1 in Medullary Thyroid Carcinoma and the Correlation with RET Mutation Status.

作者信息

Steiner Florian, Hauser-Kronberger Cornelia, Rendl Gundula, Rodrigues Margarida, Pirich Christian

机构信息

Department of Pathology, Paracelsus Medical University Salzburg, Müllner Hauptstrasse 48, A-5020 Salzburg, Austria.

Department of Nuclear Medicine and Endocrinology, Paracelsus Medical University Salzburg, Müllner Hauptstrasse 48, A-5020 Salzburg, Austria.

出版信息

Int J Mol Sci. 2016 Jul 9;17(7):1093. doi: 10.3390/ijms17071093.

DOI:10.3390/ijms17071093
PMID:27409604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4964469/
Abstract

Tenascin C expression correlates with tumor grade and indicates worse prognosis in several tumors. Epidermal growth factor receptor (EGFR) plays an important role in driving proliferation in many tumors. Loss of E-cadherin function is associated with tumor invasion and metastasis. Thyroid transcription factor-1 (TTF-1) is involved in rearranged during transfection (RET) transcription in Hirschsprung's disease. Tenascin C, EGFR, E-cadherin, TTF-1-expression, and their correlations with RET mutation status were investigated in 30 patients with medullary thyroid carcinoma (MTC) (n = 26) or C-cell hyperplasia (n = 4). Tenascin C was found in all, EGFR in 4/26, E-cadherin in 23/26, and TTF-1 in 25/26 MTC. Tenascin C correlated significantly with tumor proliferation (overall, r = 0.61, p < 0.005; RET-mutated, r = 0.81, p < 0.01). E-cadherin showed weak correlation, whereas EGFR and TTF-1 showed no significant correlation with tumor proliferation. EGFR, E-cadherin, and TTF-1 showed weak correlation with proliferation of RET-mutated tumors. Correlation between TTF-1 and tenascin C, E-cadherin, and EGFR was r = -0.10, 0.37, and 0.21, respectively. In conclusion, MTC express tenascin C, E-cadherin, and TTF-1. Tenascin C correlates significantly with tumor proliferation, especially in RET-mutated tumors. EGFR is low, and tumors expressing EGFR do not exhibit higher proliferation. TTF-1 does not correlate with RET mutation status and has a weak correlation with tenascin C, E-cadherin, and EGFR expression.

摘要

肌腱蛋白C的表达与肿瘤分级相关,且在多种肿瘤中提示预后较差。表皮生长因子受体(EGFR)在许多肿瘤的增殖过程中起重要作用。E-钙黏蛋白功能缺失与肿瘤侵袭和转移相关。甲状腺转录因子-1(TTF-1)参与先天性巨结肠病中转染重排(RET)转录过程。对30例甲状腺髓样癌(MTC)患者(n = 26)或C细胞增生患者(n = 4)的肌腱蛋白C、EGFR、E-钙黏蛋白、TTF-1表达及其与RET突变状态的相关性进行了研究。在所有MTC中均发现有肌腱蛋白C,4/26例中有EGFR,23/26例中有E-钙黏蛋白,25/26例中有TTF-1。肌腱蛋白C与肿瘤增殖显著相关(总体,r = 0.61,p < 0.005;RET突变型,r = 0.81,p < 0.01)。E-钙黏蛋白显示出弱相关性,而EGFR和TTF-1与肿瘤增殖无显著相关性。EGFR、E-钙黏蛋白和TTF-1与RET突变型肿瘤的增殖呈弱相关。TTF-1与肌腱蛋白C、E-钙黏蛋白和EGFR的相关性分别为r = -0.10、0.37和0.21。总之,MTC表达肌腱蛋白C、E-钙黏蛋白和TTF-1。肌腱蛋白C与肿瘤增殖显著相关,尤其是在RET突变型肿瘤中。EGFR表达较低,表达EGFR的肿瘤未表现出更高的增殖。TTF-1与RET突变状态无关,与肌腱蛋白C、E-钙黏蛋白和EGFR表达呈弱相关。

相似文献

1
Expression of Tenascin C, EGFR, E-Cadherin, and TTF-1 in Medullary Thyroid Carcinoma and the Correlation with RET Mutation Status.甲状腺髓样癌中腱生蛋白C、表皮生长因子受体、E-钙黏蛋白和甲状腺转录因子-1的表达及其与RET突变状态的相关性
Int J Mol Sci. 2016 Jul 9;17(7):1093. doi: 10.3390/ijms17071093.
2
Influence of RET mutations on the expression of tyrosine kinases in medullary thyroid carcinoma.REV 突变对甲状腺髓样癌中酪氨酸激酶表达的影响。
Endocr Relat Cancer. 2013 Jul 12;20(4):611-9. doi: 10.1530/ERC-12-0316. Print 2013 Aug.
3
ATF4 Targets RET for Degradation and Is a Candidate Tumor Suppressor Gene in Medullary Thyroid Cancer.ATF4靶向RET进行降解,是甲状腺髓样癌中的一个候选肿瘤抑制基因。
J Clin Endocrinol Metab. 2017 Mar 1;102(3):933-941. doi: 10.1210/jc.2016-2878.
4
MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit.微小RNA-182通过将RET致癌基因激活的核因子κB与HES1/Notch1调控回路的缺失相联系来促进癌症侵袭。
Mol Cancer. 2017 Jan 26;16(1):24. doi: 10.1186/s12943-016-0563-x.
5
Prognostic Significance of Circulating RET M918T Mutated Tumor DNA in Patients With Advanced Medullary Thyroid Carcinoma.循环RET M918T突变肿瘤DNA在晚期甲状腺髓样癌患者中的预后意义
J Clin Endocrinol Metab. 2017 Sep 1;102(9):3591-3599. doi: 10.1210/jc.2017-01039.
6
Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma.CDKN2C基因拷贝数在散发性甲状腺髓样癌中的作用
Thyroid. 2016 Nov;26(11):1553-1562. doi: 10.1089/thy.2016.0224. Epub 2016 Oct 18.
7
Overexpression and activation of EGFR and VEGFR2 in medullary thyroid carcinomas is related to metastasis.在甲状腺髓样癌中,EGFR 和 VEGFR2 的过度表达和激活与转移有关。
Endocr Relat Cancer. 2010 Jan 29;17(1):7-16. doi: 10.1677/ERC-08-0304. Print 2010 Mar.
8
Cofilin is a mediator of RET-promoted medullary thyroid carcinoma cell migration, invasion and proliferation.Cofilin 是 RET 促进的甲状腺髓样癌细胞迁移、侵袭和增殖的介质。
Mol Cell Endocrinol. 2019 Sep 15;495:110519. doi: 10.1016/j.mce.2019.110519. Epub 2019 Jul 25.
9
RET Proto-oncogene Gene Mutation Is Related to Cervical Lymph Node Metastasis in Medullary Thyroid Carcinoma.RET 原癌基因的基因突变与甲状腺髓样癌的颈部淋巴结转移相关。
Endocr Pathol. 2019 Dec;30(4):297-304. doi: 10.1007/s12022-019-09588-z.
10
Sporadic minute medullary thyroid carcinoma with a double RET mutation: A case report.散发型微小髓样甲状腺癌伴双RET突变:一例报告。
Pathol Int. 2017 Nov;67(11):580-584. doi: 10.1111/pin.12588. Epub 2017 Sep 27.

引用本文的文献

1
Targeting endothelial growth factor receptor in thyroid cancer: current concepts and future directions.甲状腺癌中内皮生长因子受体的靶向治疗:当前概念与未来方向
Med Oncol. 2025 Jun 2;42(7):233. doi: 10.1007/s12032-025-02788-0.
2
The diagnostic challenges of medullary thyroid carcinoma: A practical guide for cytopathologists.甲状腺髓样癌的诊断挑战:细胞病理学家实用指南。
Cancer Cytopathol. 2025 Jun;133(6):e70023. doi: 10.1002/cncy.70023.
3
Histopathology of C Cells and Medullary Thyroid Carcinoma.C细胞与甲状腺髓样癌的组织病理学

本文引用的文献

1
HOXB5 cooperates with NKX2-1 in the transcription of human RET.HOXB5 与 NKX2-1 共同转录人类 RET。
PLoS One. 2011;6(6):e20815. doi: 10.1371/journal.pone.0020815. Epub 2011 Jun 3.
2
The tyrosine kinase inhibitor ZD6474 blocks proliferation of RET mutant medullary thyroid carcinoma cells.酪氨酸激酶抑制剂 ZD6474 可阻断 RET 突变型甲状腺髓样癌细胞的增殖。
Endocr Relat Cancer. 2010 Nov 30;18(1):1-11. doi: 10.1677/ERC-09-0292. Print 2011 Feb.
3
Overexpression and activation of EGFR and VEGFR2 in medullary thyroid carcinomas is related to metastasis.
Recent Results Cancer Res. 2025;223:9-50. doi: 10.1007/978-3-031-80396-3_2.
4
Integrated analysis of transcription factor-mRNA-miRNA regulatory network related to immune characteristics in medullary thyroid carcinoma.甲状腺髓样癌免疫特征相关转录因子-mRNA-miRNA 调控网络的综合分析。
Front Immunol. 2023 Jan 12;13:1055412. doi: 10.3389/fimmu.2022.1055412. eCollection 2022.
5
Tenascin-C promotes bladder cancer progression and its action depends on syndecan-4 and involves NF-κB signaling activation.Tenascin-C 促进膀胱癌的进展,其作用依赖于 syndecan-4,并涉及 NF-κB 信号通路的激活。
BMC Cancer. 2022 Mar 4;22(1):240. doi: 10.1186/s12885-022-09285-x.
6
Two distinct E3 ligases, SCF and HECW1, degrade thyroid transcription factor 1 in normal thyroid epithelial and follicular thyroid carcinoma cells, respectively.两种不同的 E3 连接酶,SCF 和 HECW1,分别在正常甲状腺上皮细胞和滤泡性甲状腺癌癌细胞中降解甲状腺转录因子 1。
FASEB J. 2019 Sep;33(9):10538-10550. doi: 10.1096/fj.201900415R. Epub 2019 Jun 25.
7
Current Knowledge in Thyroid Cancer-From Bench to Bedside.甲状腺癌的当前知识——从实验室到临床
Int J Mol Sci. 2017 Jul 15;18(7):1529. doi: 10.3390/ijms18071529.
8
Medullary Thyroid Carcinoma: Recent Advances Including MicroRNA Expression.甲状腺髓样癌:包括微小RNA表达在内的最新进展
Endocr Pathol. 2016 Dec;27(4):312-324. doi: 10.1007/s12022-016-9449-0.
在甲状腺髓样癌中,EGFR 和 VEGFR2 的过度表达和激活与转移有关。
Endocr Relat Cancer. 2010 Jan 29;17(1):7-16. doi: 10.1677/ERC-08-0304. Print 2010 Mar.
4
Tenascin C in medullary thyroid microcarcinoma and C-cell hyperplasia.甲状腺髓样微小癌和C细胞增生中的腱生蛋白C
Virchows Arch. 2009 Jul;455(1):43-8. doi: 10.1007/s00428-009-0786-y. Epub 2009 May 30.
5
Medullary thyroid cancer: management guidelines of the American Thyroid Association.甲状腺髓样癌:美国甲状腺协会管理指南
Thyroid. 2009 Jun;19(6):565-612. doi: 10.1089/thy.2008.0403.
6
RET/PTC-induced cell growth is mediated in part by epidermal growth factor receptor (EGFR) activation: evidence for molecular and functional interactions between RET and EGFR.RET/PTC诱导的细胞生长部分是由表皮生长因子受体(EGFR)激活介导的:RET与EGFR之间分子和功能相互作用的证据。
Cancer Res. 2008 Jun 1;68(11):4183-91. doi: 10.1158/0008-5472.CAN-08-0413.
7
TTF-1 and RET promoter SNPs: regulation of RET transcription in Hirschsprung's disease.TTF-1与RET启动子单核苷酸多态性:先天性巨结肠症中RET转录的调控
Hum Mol Genet. 2005 Jan 15;14(2):191-204. doi: 10.1093/hmg/ddi015. Epub 2004 Nov 17.
8
The Ki67 index a prognostic marker in medullary thyroid carcinoma.Ki67指数是甲状腺髓样癌的一种预后标志物。
Br J Cancer. 2003 Dec 1;89(11):2093-7. doi: 10.1038/sj.bjc.6601453.
9
Clinical impact and functional aspects of tenascin-C expression during glioma progression.胶质瘤进展过程中肌腱蛋白-C表达的临床影响及功能方面
Int J Cancer. 2002 Mar 20;98(3):362-9. doi: 10.1002/ijc.10233.
10
Clinical significance of E-cadherin expression in thyroid neoplasms.E-钙黏蛋白在甲状腺肿瘤中表达的临床意义
J Surg Oncol. 2001 Mar;76(3):176-80. doi: 10.1002/jso.1031.